The Impatient Researcher: Opening a vial straight from the freezer
GLP-1 receptor agonists do not cause disproportionate muscle loss relative to fat, and the muscle that remains often improves in quality and function, making muscle gain achievable with proper training and nutrition
This is due, at least in part, to recent outcome trial data supporting the use of select GLP-1 RAs and SGLT-2 inhibitors to mitigate cardiovascular and renal risks in at-risk patients
Steyaert S, Lootus M, Sarabu C et al (2023) A decentralized, prospective, observational study to collect real-world data from patients with myasthenia gravis using smartphones
it's about protecting your data, your budget, and your time